Steve E. Krognes serves as Executive at Denali Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Steve E. Krognes has executed 64 insider transactions totaling $13.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 16, 2021 involved selling 22,684 shares valued at $1.5M.
Steve E. Krognes currently holds 926 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steve E. Krognes has been a net seller of DNLI stock. They have purchased $0 and sold $13.5M worth of shares.
Steve E. Krognes's most recent insider trade was on Feb 16, 2021, when they sold 22,684 shares at $64.27 per share.
Get notified when new Form 4 filings are submitted
| $70.17 |
| Discretionary |
| Feb 11, 2021 | DNLI | $28.6K | Sale | 400 | $71.43 | Discretionary |
| Jan 15, 2021 | DNLI | $921.1K | Sale | 12,981 | $70.96 | Discretionary |
| Jan 15, 2021 | DNLI | $581.0K | Sale | 8,071 | $71.99 | Discretionary |
| Jan 15, 2021 | DNLI | $1.0M | Sale | 14,147 | $73.01 | Discretionary |
| Jan 15, 2021 | DNLI | $1.0M | Sale | 14,801 | $70.10 | Discretionary |
| Aug 21, 2020 | DNLI | $64.2K | Payment | 1,954 | $32.87 | Discretionary |
| Aug 20, 2020 | DNLI | $0 | Option Exercise | 5,643 | $N/A | Discretionary |
| Mar 30, 2020 | DNLI | $27.8K | Sale | 1,428 | $19.48 | Discretionary |
| Feb 7, 2020 | DNLI | $0 | Option Exercise | 4,250 | $N/A | Discretionary |
| Aug 21, 2019 | DNLI | $36.8K | Payment | 1,977 | $18.59 | Discretionary |
| Aug 20, 2019 | DNLI | $0 | Option Exercise | 5,643 | $N/A | Discretionary |
| Dec 12, 2017 | DNLI | $0 | Conversion | 500,000 | $N/A | Discretionary |